Why Gemini? – Gemini Health

Gemini's Patented Services Provide More Opportunities to Switch Patients to More Optimal Medications

Gemini has an integrated suite of five drug cost transparency services, far beyond standard PBM RTPB services, that offer lower cost alternatives at 5 different Patient “touch points” where patients are interacting with healthcare providers regarding their prescription drugs. Additionally, providing lower cost alternatives 5 times more than the industry average enables us to provide 10 times the industry savings.

Gemini Health is the only drug cost transparency service that delivers:

Drug pricing based on Patients’ specific benefit, formulary, and other plan coverage rules
Dose-matched lower cost alternatives and the Patient and Total Savings for each
Delivery of alternatives almost 5 times the industry average
10x more savings than industry average
Delivered to prescribers, pharmacists, and patients
Delivered via EHR and via our patented web portal MedOps(R)
Reporting with actual intervention activity and associated savings as proven in claims

This combination has proven to be the most effective in achieving robust savings, as reported by our customers.

5 times the alternatives + 5 times the services/touch points = 10 times the savings

Gemini has an integrated suite of five drug cost transparency services, far beyond standard PBM RTPB services, that offer lower cost alternatives at 5 different Patients “touch points” where patients are interacting with healthcare providers regarding their prescription drugs. Additionally, providing lower cost alternatives 5 times more than the industry average¹ enables us to provide 10 times the industry savings.

Beyond savings, Gemini offers improved member and provider partner satisfaction including:

Decreased number of prior authorizations
Reduced pharmacy call backs, saving time for members and providers
Reduced number of member complaints based on reduced drug cost, moves to 90-day fills and fewer drug hassles
Impact on adherence based on lower cost medications

Gemini also provides a unique, proven competitive advantage and differentiator for payer’s sales and marketing efforts, resulting in:

Competitive advantage to win as an integrated health plan over standalone PBM offerings/capabilities
Avoiding misaligned/conflicted PBM incentives
Improved Member/Employee experience

Our Mission

Gemini Health delivers actionable prescription drug cost and benefit information to patients, pharmacists, and prescribers, enabling informed prescribing decisions that reduce prescription drug costs and improve patient health and satisfaction.

Our History

Gemini Health was founded in 2014 by seasoned healthcare executives and clinicians with decades of experience in healthcare and health information technology and a successful track record in start-up companies. Gemini Health is based in Sausalito, California and has employees throughout the United States. Gemini Health was formed to reduce healthcare costs through drug cost transparency at the point of care.

Our Team

The Gemini Health team is comprised of seasoned executives and clinicians with a long history of leadership and success in healthcare and healthcare information technology related to prescription drugs, electronic health records, and healthcare data exchange and standards.

James J. Cargilo

Privacy and Security

Jackie Choy

Finance & Administration

Edward J. Fotsch, MD

CEO/Strategy

Denise Lindgren

Operations

Michael McGee

Administration

Mickey McGlynn

Provider Engagement & Implementation

Roger Pinsonneault, R.Ph.

Product Innovation

David Spivak

Information Technology

Our Advisors

The Gemini Health team of advisors is comprised of executives with decades of experience working in major health systems, venture capital, government and advisory roles, employer benefits, business strategy, and Big Data.

Forest Baskett, PhD

General Partner at New Enterprise Associates (Venture Capital)

Kent Bradley, MD, MPH, MBA

Former Safeway CMO & Principal of BTN Advisor

Matt Nye, Pharm.D.

Former Vice President, Pharmacy Kaiser Permanente and Blue Shield of California

Frank G. Opelka, MD, FACS

LSU Executive Vice President for Healthcare Redesign & VP American College of Surgeons

John R. Peterson

Managing Director at Cleary Gull, Inc. (Investment Banking)

Jacob Reider, MD

Former Deputy National Coordinator, ONC & Principal RS Partners

Tom Reilly

Chief Executive Officer of Cloudera (Big Data Firm)

MedTherapy Advisory Board

The MedTherapy Advisory Board is an independent group of clinicians who provide oversite and make recommendations on clinical topics related to therapeutic alternatives provided in all Gemini services. Clinician backgrounds include independent clinical practice, academics, health systems and payers.

Sam Brondfield, M.D.
Consulting Physician, Hematology/Oncology

Mackenzie Clark, Pharm.D, APh, BCPS, BCGP
Program Pharmacist
UCSF School of Pharmacy

Dwight Davis, Pharm.D.
Director, Clinical Services &
Payer Engagement, Gemini Health

Edward J. Fotsch, M.D.
Chief Executive Officer, Gemini Health

David Paul Hon, Pharm.D.
Pharmacist Consultant

James Naughton, M.D.
Consulting Physician

Brian Nguyen, Pharm.D.
Pharmacist, Formulary Strategy
Blue Shield of California

Matt Nye, Pharm.D.
Pharmacist Consultant

Roger Pinsonneault
Senior Vice President
Chief Innovation Officer

Norman Rosen M.D.
Consulting Physician

Richard G. Williams, M.D.
Consulting Physician

Johanna Yee, Pharm.D.
Pharmacist, Formulary Strategy
Blue Shield of California